Cargando…

American cutaneous leishmaniasis in French Guiana: a retrospective comparison between liposomal amphotericin B and meglumine antimoniate

Detalles Bibliográficos
Autores principales:	Senchyna, A., Simon, S., Cissé, H., Ginouves, M., Prevot, G., Alcoba, G., Demar, M., Couppie, P., Blaizot, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497058/ https://www.ncbi.nlm.nih.gov/pubmed/32078162 http://dx.doi.org/10.1111/bjd.18964

Ejemplares similares

Validation of Swab Sampling and SYBR Green-Based Real-Time PCR for the Diagnosis of Cutaneous Leishmaniasis in French Guiana
por: Blaizot, Romain, et al.
Publicado: (2021)

American cutaneous leishmaniasis in French Guiana: an epidemiological update and study of environmental risk factors
por: Loiseau, Rémi, et al.
Publicado: (2019)

Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP
por: Simon, Stephane, et al.
Publicado: (2017)

Leishmania naiffi and lainsoni in French Guiana: Clinical features and phylogenetic variability
por: Ducharme, Océane, et al.
Publicado: (2020)

Outbreak of Cutaneous Leishmaniasis among military personnel in French Guiana, 2020: Clinical, phylogenetic, individual and environmental aspects
por: Henry, Kim, et al.
Publicado: (2021)

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
por: Layegh, Pouran, et al.
Publicado: (2011)

Immunoblot for the Diagnosis of Cutaneous Leishmaniasis in French Guiana
por: Menu, Estelle, et al.
Publicado: (2021)

Clinical and immunological spectra of human cutaneous leishmaniasis in North Africa and French Guiana
por: Saidi, Nasreddine, et al.
Publicado: (2023)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
por: Vargas, Deninson Alejandro, et al.
Publicado: (2019)

Updated estimation of cutaneous leishmaniasis incubation period in French Guiana
por: Blaizot, Romain, et al.
Publicado: (2023)

Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saül, French Guiana
por: Martin-Blondel, Guillaume, et al.
Publicado: (2015)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
por: Yazdanpanah, Mohamad Javad, et al.
Publicado: (2011)

RESOLUTION OF CUTANEOUS LEISHMANIASIS AFTER ACUTE ECZEMA DUE TO INTRALESIONAL MEGLUMINE ANTIMONIATE
por: Vasconcellos, Erica de Camargo Ferreira e, et al.
Publicado: (2014)

Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)
por: Gómez, María Adelaida, et al.
Publicado: (2020)

Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia
por: Rojas Cabrera, Ernesto, et al.
Publicado: (2022)

Spectrum of skin diseases in Maroon villages of the Maroni area, French Guiana
por: Valentin, Julie, et al.
Publicado: (2022)

Fungal Density in Lobomycosis in French Guiana: A Proposal for a New Clinico-Histological and Therapeutic Classification
por: Grotta, Geoffrey, et al.
Publicado: (2023)

Spectrum of skin diseases in Amerindian villages of the Upper Oyapock, French Guiana
por: Malmontet, Thomas, et al.
Publicado: (2020)

The effect of Nd:YAG laser therapy on cutaneous leishmaniasis compared to intralesional meglumine antimoniate
por: Omidian, Mohammad, et al.
Publicado: (2019)

Clinical and histological characteristics, and management of melanoma in French Guiana, 2007–2018
por: Broly, Marine, et al.
Publicado: (2020)

Cytological and Histopathological Spectrum of Histoplasmosis: 15 Years of Experience in French Guiana
por: Drak Alsibai, Kinan, et al.
Publicado: (2020)

Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate
por: Perez-Franco, Jairo E., et al.
Publicado: (2016)

Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis
por: Berger, Brandon A., et al.
Publicado: (2017)

Frequency and distribution of mixed Plasmodiumfalciparum-vivax infections in French Guiana between 2000 and 2008
por: Ginouves, Marine, et al.
Publicado: (2015)

First description of bullous lupus associated with cutaneous leishmaniasis: coincidence or trigger?
por: Bertin, Chloé, et al.
Publicado: (2021)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

FACTORS ASSOCIATED TO ADHERENCE TO DIFFERENT TREATMENT SCHEMES WITH MEGLUMINE ANTIMONIATE IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS
por: Ribeiro, Madelon Novato, et al.
Publicado: (2014)

Dressings Combined with Injection of Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial
por: Khatami, Alireza, et al.
Publicado: (2013)

PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS
por: LYRA, Marcelo Rosandiski, et al.
Publicado: (2016)

Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran
por: Aflatoonian, Mohammad Reza, et al.
Publicado: (2019)

Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis
por: Berenguer, Diana, et al.
Publicado: (2019)

Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime(®)) in Cutaneous Leishmaniasis
por: Albalawi, Aishah E., et al.
Publicado: (2021)

Skin and soft‐tissue infections associated with Aeromonas species in French Guiana: an 11‐year retrospective study
por: Devos, M., et al.
Publicado: (2020)

Comparison of Disseminated Histoplasmosis with and without Cutaneo-Mucous Lesions in Persons Living with HIV in French Guiana
por: Morote, Sophie, et al.
Publicado: (2020)

Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre
por: da Silva, Rosiana Estéfane, et al.
Publicado: (2016)

Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis
por: Brito, Nayara C., et al.
Publicado: (2019)

Teledermatology Use in Remote Areas of French Guiana: Experience From a Long-Running System
por: Messagier, Anne-Laure, et al.
Publicado: (2019)

Leprosy in French Guiana, 2015 to 2021: Dynamics of a Persistent Public Health Problem
por: PETIOT, Aurore, et al.
Publicado: (2023)

Unraveling the genetic diversity and phylogeny of Leishmania RNA virus 1 strains of infected Leishmania isolates circulating in French Guiana
por: Tirera, Sourakhata, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_csedjrdbppe1velnp7lil2qln3